Table 1.
Patient, cytology and histopathological characteristics (N = 567)
| Variables | |
|---|---|
| Median (IQR) age, years | 67.7 (55.6, 75.7) |
| Gender, n (%) | |
| Men | 342 (60.3) |
| Women | 225 (39.7) |
| Smoking history, n (%) | |
| Non‐smoker | 240 (42.3) |
| Current smoker | 87 (15.3) |
| Previous smoker | 231 (40.7) |
| Not known | 9 (1.6) |
| Type of haematuria, n (%) | |
| Visible | 395 (69.7) |
| Non‐visible | 172 (30.3) |
| Urine cytology, n (%) | |
| Inadequate cellular content/non‐diagnostic | 13 (2.3) |
| Negative | 512 (90.3) |
| Atypical | 21 (3.7) |
| Suspicious/consistent with neoplastic cells | 21 (3.7) |
| Bladder cancer, n (%) | 39 (6.9) |
| Upper tract TCC, n (%) | 8 (1.4) |
| Bladder cancer grade, n (%) | |
| G1 | 6 (15.4) |
| G2 | 14 (35.9) |
| G3 | 19 (48.7) |
| Concurrent CIS, n (%) | 6 (15.4) |
| Bladder cancer stage, n (%) | |
| CIS | 0 (0) |
| pTa | 24 (61.5) |
| pT1 | 8 (20.5) |
| ≥pT2 | 7 (17.9) |
CIS, carcinoma in situ; IQR, interquartile range.